Business Description

This high-end beauty device company is looking for equity and growth partners to accelerate their success in the market. They offer FDA-approved Class II medical devices embedded with patented technology, setting them apart from competitors and driving growth. Their products are suitable for home use, medical spas, and retail locations offering aesthetic services, contributing to a global customer base. With a strong financial performance showing a TTM EBITDA of $5.197 million through February 2022 and a 2021 EBITDA of approximately $4.691 million, the company is rebounding towards pre-COVID levels. Their FDA 510(k) classifications for select devices further showcase their commitment to quality and innovation. The company also boasts agreements with key customers and the ability to produce white-label devices with the same FDA-approved technology. This company's success lies in its unique, patented beauty devices that cater to a growing market seeking at-home solutions for skin care and aesthetic needs. Their global reach, strong financial performance, and differentiation